ARTICLE | Distillery Therapeutics
Therapeutics: GATA binding protein 2 (GATA2); insulin-like growth factor-2 (IGF-2)
March 26, 2015 7:00 AM UTC
In vitro and mouse studies suggest inhibiting GATA2-IGF2 signaling could resensitize prostate cancer to chemotherapy. In chemotherapy-resistant human prostate cancer cells, levels of the transcription...